From Financial Modeling Prep: 2025-02-05 03:00:03

In summary, Medexus Pharmaceuticals, a specialty pharmaceutical company, is preparing to release its quarterly earnings with an estimated EPS of $0.02 and projected revenue of $40.8 million. The company’s financial metrics include a P/E ratio of 29.10, a price-to-sales ratio of 0.64, and a debt-to-equity ratio of 1.31. A conference call is scheduled for February 6, 2025, to discuss the financial results for the third fiscal quarter ending December 31, 2024.



Read more at Financial Modeling Prep:: Medexus Pharmaceuticals Quarterly Earnings Overvie…